1. Home
  2. EXAS vs ALTR Comparison

EXAS vs ALTR Comparison

Compare EXAS & ALTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXAS
  • ALTR
  • Stock Information
  • Founded
  • EXAS 1995
  • ALTR 1985
  • Country
  • EXAS United States
  • ALTR United States
  • Employees
  • EXAS N/A
  • ALTR N/A
  • Industry
  • EXAS Medical Specialities
  • ALTR Computer Software: Prepackaged Software
  • Sector
  • EXAS Health Care
  • ALTR Technology
  • Exchange
  • EXAS Nasdaq
  • ALTR Nasdaq
  • Market Cap
  • EXAS 12.3B
  • ALTR 8.0B
  • IPO Year
  • EXAS N/A
  • ALTR 2017
  • Fundamental
  • Price
  • EXAS $71.05
  • ALTR $108.72
  • Analyst Decision
  • EXAS Strong Buy
  • ALTR Hold
  • Analyst Count
  • EXAS 13
  • ALTR 6
  • Target Price
  • EXAS $79.00
  • ALTR $90.67
  • AVG Volume (30 Days)
  • EXAS 1.4M
  • ALTR 523.7K
  • Earning Date
  • EXAS 11-05-2024
  • ALTR 10-30-2024
  • Dividend Yield
  • EXAS N/A
  • ALTR N/A
  • EPS Growth
  • EXAS N/A
  • ALTR N/A
  • EPS
  • EXAS N/A
  • ALTR 0.31
  • Revenue
  • EXAS $2,612,011,000.00
  • ALTR $627,213,000.00
  • Revenue This Year
  • EXAS $15.53
  • ALTR $8.65
  • Revenue Next Year
  • EXAS $13.78
  • ALTR $9.30
  • P/E Ratio
  • EXAS N/A
  • ALTR $352.35
  • Revenue Growth
  • EXAS 13.54
  • ALTR 6.85
  • 52 Week Low
  • EXAS $40.62
  • ALTR $57.59
  • 52 Week High
  • EXAS $79.62
  • ALTR $113.12
  • Technical
  • Relative Strength Index (RSI)
  • EXAS 55.81
  • ALTR 72.39
  • Support Level
  • EXAS $68.61
  • ALTR $101.58
  • Resistance Level
  • EXAS $71.49
  • ALTR $113.12
  • Average True Range (ATR)
  • EXAS 1.91
  • ALTR 4.45
  • MACD
  • EXAS -0.34
  • ALTR 1.22
  • Stochastic Oscillator
  • EXAS 50.41
  • ALTR 85.99

About EXAS Exact Sciences Corporation

Exact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a noninvasive stool-based DNA test, is a pre-cancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, or MRD, colorectal cancer screening, and multicancer screening.

About ALTR Altair Engineering Inc.

Altair Engineering Inc is a provider of enterprise-class engineering software enabling origination of the entire product lifecycle from concept design to in-service operation. The integrated suite of software provided by the company optimizes design performance across multiple disciplines encompassing structures, motion, fluids, thermal management, system modeling, and embedded systems. It operates through two segments: Software which includes the portfolio of software products such as solvers and optimization technology products, modeling and visualization tools, industrial and concept design tools, and others; and Client Engineering Services which provides client engineering services to support customers. Majority of its revenue comes from the software segment.

Share on Social Networks: